Cancer-induced anorexia in tumor-bearing mice is dependent on cyclooxygenase-1

Brain, Behavior, and Immunity

Volumn 29, Issue , 2013, Pages 124-135

  Ruud, Johan ^a   Nilsson, Anna ^a   Engström Ruud, Linda ^a   Wang, Wenhua ^b   Nilsberth, Camilla ^a   Iresjö, Britt Marie ^b   Lundholm, Kent ^b   Engblom, David ^a   Blomqvist, Anders ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer anorexia cachexia; Cyclooxygenase; Microsomal prostaglandin E synthase 1; Prostaglandin E2

Indexed keywords

3 METHYLCHOLANTHRENE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2;

ANOREXIA; ARTICLE; BLOOD VESSEL; BODY TEMPERATURE MEASUREMENT; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE DELETION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; WEIGHT REDUCTION;

ANIMALS; ANOREXIA; BODY TEMPERATURE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DNA, COMPLEMENTARY; EATING; FEMALE; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MICE; NEOPLASMS, EXPERIMENTAL; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; RNA; SIGNAL TRANSDUCTION;

EID: 84873431418     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.12.020     Document Type: Article

References (69)

1. Axelsson H., Lonnroth C., Wang W., Svanberg E., Lundholm K. Cyclooxygenase inhibition in early onset of tumor growth and related angiogenesis evaluated in EP1 and EP3 knockout tumor-bearing mice. Angiogenesis 2005, 8:339-348.
2. Bosaeus I., Daneryd P., Svanberg E., Lundholm K. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int. J. Cancer 2001, 93:380-383.
3. Brown J.R., DuBois R.N. COX-2: a molecular target for colorectal cancer prevention. J. Clin. Oncol. 2005, 23:2840-2855.
4. Cahlin C., Gelin J., Andersson M., Lonnroth C., Lundholm K. The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors. Int. J. Oncol. 2005, 27:913-923.
5. Cahlin C., Gelin J., Delbro D., Lonnroth C., Doi C., Lundholm K. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids. Cancer Res. 2000, 60:1742-1749.
6. Cahlin C., Korner A., Axelsson H., Wang W., Lundholm K., Svanberg E. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia. Cancer Res. 2000, 60:5488-5493.
7. Cao C., Matsumura K., Yamagata K., Watanabe Y. Cyclooxygenase-2 is induced in brain blood vessels during fever evoked by peripheral or central administration of tumor necrosis factor. Brain Res. Mol. Brain Res. 1998, 56:45-56.
8. Daikoku T., Tranguch S., Chakrabarty A., Wang D., Khabele D., Orsulic S., Morrow J.D., Dubois R.N., Dey S.K. Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Cancer Res. 2007, 67:5285-5292.
9. Daikoku T., Tranguch S., Trofimova I.N., Dinulescu D.M., Jacks T., Nikitin A.Y., Connolly D.C., Dey S.K. Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. Cancer Res. 2006, 66:2527-2531.
10. Daikoku T., Wang D., Tranguch S., Morrow J.D., Orsulic S., DuBois R.N., Dey S.K. Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res. 2005, 65:3735-3744.
11. Davis T.W., Zweifel B.S., O'Neal J.M., Heuvelman D.M., Abegg A.L., Hendrich T.O., Masferrer J.L. Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting. J. Pharmacol. Exp. Ther. 2004, 308:929-934.
12. Doggett N.S., Jawaharlal K. Some observations on the anorectic activity of prostaglandin F2alpha. Br. J. Pharmacol. 1977, 60:409-415.
13. Eckel L.A., Langhans W., Kahler A., Campfield L.A., Smith F.J., Geary N. Chronic administration of OB protein decreases food intake by selectively reducing meal size in female rats. Am. J. Physiol. 1998, 275:R186-R193.
14. Eguchi N., Kaneko T., Urade Y., Hayashi H., Hayaishi O. Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats. J. Pharmacol. Exp. Ther. 1992, 262:1110-1120.
15. Ek M., Engblom D., Saha S., Blomqvist A., Jakobsson P.J., Ericsson-Dahlstrand A. Inflammatory response: pathway across the blood-brain barrier. Nature 2001, 410:430-431.
16. Ek M., Kurosawa M., Lundeberg T., Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J. Neurosci. 1998, 18:9471-9479.
17. Elander L., Engstrom L., Hallbeck M., Blomqvist A. IL-1beta and LPS induce anorexia by distinct mechanisms differentially dependent on microsomal prostaglandin E synthase-1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R258-R267.
18. Elander L., Ruud J., Korotkova M., Jakobsson P.J., Blomqvist A. Cyclooxygenase-1 mediates the immediate corticosterone response to peripheral immune challenge induced by lipopolysaccharide. Neurosci. Lett. 2010, 470:10-12.
19. Elander N., Ungerback J., Olsson H., Uematsu S., Akira S., Soderkvist P. Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APC(Min/+) mice. Biochem. Biophys. Res. Commun. 2008, 372:249-253.
20. Engblom D., Saha S., Engstrom L., Westman M., Audoly L.P., Jakobsson P.J., Blomqvist A. Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat. Neurosci. 2003, 6:1137-1138.
21. Engström L., Ruud J., Eskilsson A., Larsson A., Mackerlova L., Kugelberg U., Qian H., Vasilache A.M., Larsson P., Engblom D., Sigvardsson M., Jönsson J.-I., Blomqvist A. Lipopolysaccharide-induced fever depends on prostaglandin E2 production specifically in brain endothelial cells. Endocrinology 2012, 153:4849-4861.
22. Fearon K., Strasser F., Anker S.D., Bosaeus I., Bruera E., Fainsinger R.L., Jatoi A., Loprinzi C., MacDonald N., Mantovani G., Davis M., Muscaritoli M., Ottery F., Radbruch L., Ravasco P., Walsh D., Wilcock A., Kaasa S., Baracos V.E. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011, 12:489-495.
23. Garcia-Bueno B., Serrats J., Sawchenko P.E. Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation by inflammatory stimuli. J. Neurosci. 2009, 29:12970-12981.
24. Gelin J., Andersson C., Lundholm K. Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia. Cancer Res. 1991, 51:880-885.
25. Gelin J., Moldawer L.L., Lonnroth C., deMan P., Svanborg-Eden C., Lowry S.F., Lundholm K.G. Appearance of hybridoma growth factor/interleukin-6 in the serum of mice bearing a methylcholanthrene-induced sarcoma. Biochem. Biophys. Res. Commun. 1988, 157:575-579.
26. Gupta R.A., Tejada L.V., Tong B.J., Das S.K., Morrow J.D., Dey S.K., DuBois R.N. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res. 2003, 63:906-911.
27. Hanaka H., Pawelzik S.C., Johnsen J.I., Rakonjac M., Terawaki K., Rasmuson A., Sveinbjornsson B., Schumacher M.C., Hamberg M., Samuelsson B., Jakobsson P.J., Kogner P., Radmark O. Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells. Proc. Natl. Acad. Sci. USA 2009, 106:18757-18762.
28. Hellerstein M.K., Meydani S.N., Meydani M., Wu K., Dinarello C.A. Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J. Clin. Invest. 1989, 84:228-235.
29. Horsley V., Pavlath G.K. Prostaglandin F2α stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J. Cell Biol. 2003, 161:111-118.
30. Kamei D., Murakami M., Sasaki Y., Nakatani Y., Majima M., Ishikawa Y., Ishii T., Uematsu S., Akira S., Hara S., Kudo I. Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis. Biochem. J. 2010, 425:361-371.
31. Lal J. Possible role of prostaglandins in the regulation of food intake in the newborn rat. Arch. Int. Pharmacodyn. Ther. 1984, 272:140-149.
32. Langenbach R., Morham S.G., Tiano H.F., Loftin C.D., Ghanayem B.I., Chulada P.C., Mahler J.F., Lee C.A., Goulding E.H., Kluckman K.D., Kim H.S., Smithies O. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995, 83:483-492.
33. Langhans W., Harlacher R., Scharrer E. Verapamil and indomethacin attenuate endotoxin-induced anorexia. Physiol. Behav. 1989, 46:535-539.
34. Levine A.S., Morley J.E. The effect of prostaglandins (PGE2 and PGF2 alpha) on food intake in rats. Pharmacol. Biochem. Behav. 1981, 15:735-738.
35. Lonnroth C., Moldawer L.L., Gelin J., Kindblom L., Sherry B., Lundholm K. Tumor necrosis factor-alpha and interleukin-1 alpha production in cachectic, tumor-bearing mice. Int. J. Cancer 1990, 46:889-896.
36. Lonnroth C., Svaninger G., Gelin J., Cahlin C., Iresjo B., Cvetkovska E., Edstrom S., Andersson M., Svanberg E., Lundholm K. Effects related to indomethacin prolonged survival and decreased tumor-growth in a mouse-tumor model with cytokine dependent cancer cachexia. Int. J. Oncol. 1995, 7:1405-1413.
37. Lugarini F., Hrupka B.J., Schwartz G.J., Plata-Salaman C.R., Langhans W. A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283:R862-R868.
38. Lundholm K., Edstrom S., Ekman L., Karlberg I., Bylund A.C., Schersten T. A comparative study of the influence of malignant tumor on host metabolism in mice and man: evaluation of an experimental model. Cancer 1978, 42:453-461.
39. Lundholm K., Gelin J., Hyltander A., Lonnroth C., Sandstrom R., Svaninger G., Korner U., Gulich M., Karrefors I., Norli B., et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res. 1994, 54:5602-5606.
40. Mnich S.J., Veenhuizen A.W., Monahan J.B., Sheehan K.C., Lynch K.R., Isakson P.C., Portanova J.P. Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2. J. Immunol. 1995, 155:4437-4444.
41. Morgan E.T., Goralski K.B., Piquette-Miller M., Renton K.W., Robertson G.R., Chaluvadi M.R., Charles K.A., Clarke S.J., Kacevska M., Liddle C., Richardson T.A., Sharma R., Sinal C.J. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab. Dispos. 2008, 36:205-216.
42. Murakami M., Kudo I. Prostaglandin E synthase: a novel drug targetfor inflammation and cancer. Curr. Pharm. Des. 2006, 12:943-954.
43. Nakanishi M., Montrose D.C., Clark P., Nambiar P.R., Belinsky G.S., Claffey K.P., Xu D., Rosenberg D.W. Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Res. 2008, 68:3251-3259.
44. Ohinata K., Suetsugu K., Fujiwara Y., Yoshikawa M. Activation of prostaglandin E receptor EP4 subtype suppresses food intake in mice. Prostag. Oth. Lipid M. 2006, 81:31-36.
45. Ohinata K., Takagi K., Biyajima K., Fujiwara Y., Eguchi N., Urade Y., Asakawa A., Fujimiya M., Inui A., Yoshikawa M. Central prostaglandin D(2) stimulates food intake via the neuropeptide Y system in mice. FEBS Lett. 2008, 582:679-684.
46. Pecchi E., Dallaporta M., Thirion S., Salvat C., Berenbaum F., Jean A., Troadec J.D. Involvement of central microsomal prostaglandin E synthase-1 in IL-1beta-induced anorexia. Physiol. Genomics 2006, 25:485-492.
47. Pecchi E., Dallaporta M., Jean A., Thirion S., Troadec J.D. mPGES-1 knock-out mice are resistant to cancer-induced anorexia despite the absence of central mPGES-1 up-regulation in wild-type anorexic mice. J. Neuroimmunol. 2008, 13:104-114.
48. Plata-Salaman C.R. Meal patterns in response to the intracerebroventricular administration of interleukin-1 beta in rats. Physiol. Behav. 1994, 55:727-733.
49. Portanova J.P., Zhang Y., Anderson G.D., Hauser S.D., Masferrer J.L., Seibert K., Gregory S.A., Isakson P.C. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med. 1996, 184:883-891.
50. Pourtau L., Leemburg S., Roux P., Leste-Lasserre T., Costaglioli P., Garbay B., Drutel G., Konsman J.P. Hormonal, hypothalamic and striatal responses to reduced body weight gain are attenuated in anorectic rats bearing small tumors. Brain Behav. Immun. 2011, 25:777-786.
51. Ruud J., Backhed F., Engblom D., Blomqvist A. Deletion of the gene encoding MyD88 protects from anorexia in a mouse tumor model. Brain Behav. Immun. 2010, 24:554-557.
52. Ruud J., Blomqvist A. Identification of rat brainstem neuronal structures activated during cancer-induced anorexia. J. Comp. Neurol. 2007, 504:275-286.
53. Samuelsson B., Morgenstern R., Jakobsson P.J. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol. Rev. 2007, 59:207-224.
54. Sandstrom R., Gelin J., Lundholm K. The effect of indomethacin on food and water intake, motor activity and survival in tumour-bearing rats. Eur. J. Cancer 1990, 26:811-814.
55. Saper C.B., Romanovsky A.A., Scammell T.E. Neural circuitry engaged by prostaglandins during the sickness syndrome. Nat. Neurosci. 2012, 15:1088-1095.
56. Scaramuzzi O.E., Baile C.A., Mayer J. Prostaglandins and food intake of rats. Experientia 1971, 27:256-257.
57. Schneider A., Guan Y., Zhang Y., Magnuson M.A., Pettepher C., Loftin C.D., Langenbach R., Breyer R.M., Breyer M.D. Generation of a conditional allele of the mouse prostaglandin EP4 receptor. Genesis 2004, 40:7-14.
58. Smith C.J., Zhang Y., Koboldt C.M., Muhammad J., Zweifel B.S., Shaffer A., Talley J.J., Masferrer J.L., Seibert K., Isakson P.C. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. USA 1998, 95:13313-13318.
59. Steinbach G., Lynch P.M., Phillips R.K.S., Wallace M.H., Hawk E., Gordon G.B., Wakabayashi N., Saunders B., Shen Y., Fujimura T., Su L.-K., Levin B., Godio L., Patterson S., Rodriguez-Bigas M.A., Jester S.L., King K.L., Schumacher M., Abbruzzese J., DuBois R.N., Hittelman W.N., Zimmerman S., Sherman J.W., Kelloff G. The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis. N. Engl. J. Med. 2000, 342:1946-1952.
60. Tisdale M.J. Cancer cachexia. Curr. Opin. Gastroenterol. 2010, 26:146-151.
61. Tracey K.J., Wei H., Manogue K.R., Fong Y., Hesse D.G., Nguyen H.T., Kuo G.C., Beutler B., Cotran R.S., Cerami A. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 1988, 167:1211-1227.
62. Trebino C.E., Stock J.L., Gibbons C.P., Naiman B.M., Wachtmann T.S., Umland J.P., Pandher K., Lapointe J.M., Saha S., Roach M.L., Carter D., Thomas N.A., Durtschi B.A., McNeish J.D., Hambor J.E., Jakobsson P.J., Carty T.J., Perez J.R., Audoly L.P. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl. Acad. Sci. USA 2003, 100:9044-9049.
63. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., Schutz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 1999, 23:99-103.
64. Wang W., Andersson M., Lonnroth C., Svanberg E., Lundholm K. Anorexia and cachexia in prostaglandin EP1 and EP3 subtype receptor knockout mice bearing a tumor with high intrinsic PGE2 production and prostaglandin related cachexia. J. Exp. Clin. Cancer Res. 2005, 24:99-107.
65. Wang W., Andersson M., Lonnroth C., Svanberg E., Lundholm K. Prostaglandin E and prostacyclin receptor expression in tumor and host tissues from MCG 101-bearing mice. a model with prostanoid-related cachexia. Int. J. Cancer 2005, 115:582-590.
66. Wang W., Lonnroth C., Svanberg E., Lundholm K. Cytokine and cyclooxygenase-2 protein in brain areas of tumor-bearing mice with prostanoid-related anorexia. Cancer Res. 2001, 61:4707-4715.
67. West D.B., Greenwood M.R., Marshall K.A., Woods S.C. Lithium chloride, cholecystokinin and meal patterns: evidence that cholecystokinin suppresses meal size in rats without causing malaise. Appetite 1987, 8:221-227.
68. Yang L., Yamagata N., Yadav R., Brandon S., Courtney R.L., Morrow J.D., Shyr Y., Boothby M., Joyce S., Carbone D.P., Breyer R.M. Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. J. Clin. Invest. 2003, 111:727-735.
69. Zhang Y., Shaffer A., Portanova J., Seibert K., Isakson P.C. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production. J. Pharmacol. Exp. Ther. 1997, 283:1069-1075.